Navigation Links
Dinosaur DNA? New Patent Covers Degraded DNA recovery

live ancient bacteria and fungi fossilized in amber.

By reconstituting nucleic acid molecules that have been degraded but still contain useful information scientists at MatrixDesign are able to create a template from which to multiply the genetic material. That process is repeated until the genetic material is substantially representative -- at microscopic levels -- of the species from which the degraded sample was obtained.

Dr. Ensley and his team hope to apply this new technology to products they will make available later this year. "We don't plan to turn house cats into saber tooth cats or create a Jurassic Theme Park anytime soon. But we do think this breakthrough has many applications yet to be discovered and we look forward to working with our colleagues to thoroughly examine all the possibilities," says Dr. Ensley.

Dr. Ensley is the Chairman of MatrixDesign, a biotechnology company that analyzes the genomics of human tissues and uses the information to produce high performance wound healing and tissue regeneration products, and the CEO of DermaPlus, a science-based skin care company. Dr. Ensley is a Fellow of the American Academy of Microbiology and holds an Adjunct Professorship at the University of Arizona.


'"/>

Source:PharmaLive


Page: 1 2

Related biology news :

1. Dinosaurs -- stones did not help with digestion
2. Dinosaur extinction didnt cause the rise of present-day mammals, claim researchers
3. Dinosaur hearing, listening to muscle noise, quieter cubicles
4. Nanogen Issued Patent for Electronic Microarray With Memory
5. Low oxygen likely made Great Dying worse, greatly delayed recovery
6. Time and money make a difference in endangered species recovery
7. Iraqs marshes show progress toward recovery
8. UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery
9. Fish species plays surprise role in aiding coral reef recovery
10. No-scalpel vasectomies by skilled surgeons may speed recovery
Post Your Comments:
(Date:12/3/2009)... 3, 2009) Van Andel Research Institute (VARI) ... (ABA) works at the molecular level to help plants respond ... findings, published in the journal Nature , could help ... and combat global food shortages. The findings could also ...
(Date:12/3/2009)... the past three years in the troposphere (lower atmosphere) ... results, which are the first of their kind in ... between 2002 and 2005. , Over recent years, physicists ... carbon dioxide (CO2) levels, and how these have evolved ...
(Date:12/2/2009)... cigarette smoke have an increased risk of developing lung cancer ... of this study are published in Cancer Epidemiology, Biomarkers ... Cancer Research, as part of a special tobacco focus in ... 219,000 Americans will be diagnosed with lung cancer; more than ...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 1Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 2Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 3Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 4Procter 26 Gamble Pharmaceuticals Launches Asacol 28R 29 HD 28mesalamine 29 Delayed Release Tablets 4692 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 1Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 2Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 3Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 4Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 5Landmark Study for GSKs Cervical Cancer Vaccine Published in The Lancet 4690 6Mixed Marks for Swine Flu Updates 50875 1Mixed Marks for Swine Flu Updates 50875 2
... DALLAS July 6, 2008 Tiny strands of genetic material ... as major players in gene regulation, the process inside cells that ... to fight disease. , The idea that RNA (ribonucleic acid) ... it has been unclear how RNA strands might regulate the process. ...
... Diversity among the ancestors of such marine creatures as ... rise beginning 144 million years ago with no clear ... This contradicts previous work showing dramatic increases beginning 248 ... diversity., "Some of the time periods in the past ...
... Mass., July 3, 2008 -- Sirtris, a GlaxoSmithKline company ... treat diseases of aging such as Type 2 Diabetes, ... today,s online edition of Cell Metabolism that ... showed an overall health improvement, including improved bone health, ...
Other Biology News:UT Southwestern researchers identify new targets for RNAs that regulate genes 2UT Southwestern researchers identify new targets for RNAs that regulate genes 3Ancient marine invertebrate diversity less explosive than thought 2Ancient marine invertebrate diversity less explosive than thought 3Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3
(Date:12/2/2009)... SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced ... at The American Society of Hematology 51st Annual Meeting ... presented on the clinical results from the Phase 1 ... pharmacokinetic/pharmacodynamic (PK/PD) profile in dose levels ranging from 100 ...
(Date:12/2/2009)... China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,("Simcere" ... a leading pharmaceutical company,specializing in the development, manufacturing, ... China, today announced that 105 of,its drugs have ... which was issued by China,s Ministry of Human ...
(Date:12/2/2009)... -- The world is going through,extraordinary times; markets are ... industries. It turns out that the pharma industry has ... take a,vacation. , During the ... Johnson & Johnson inaugurated an R&D center in Shanghai, ...
(Date:12/2/2009)... to the National Institute of Health, 40 percent to 45 ... of diabetic retinopathy. Diabetic retinopathy, damage to the retina ... blindness in people with diabetes and is one of the ... percent of all patients who,ve had diabetes for 10 years ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
... Support R&D Efforts and Clinical Trials Advancing,the BiTE ... Micromet, Inc.,(Nasdaq: MITI ) ("Micromet" or ... for the treatment of cancer,inflammation and autoimmune diseases, ... agreement with various institutional investors to raise,$40 million ...
... 19 - 22,2008, the fairgrounds in Dusseldorf, Germany ... - World Forum for Medicine. As the,leading international ... will,feature about 4,300 exhibitors, two major congresses, an ... at MEDICA 2008 will include the latest products ...
... BOSTON, Sept. 30 Solos Endoscopy, Inc. (Pink,Sheets: ... intends to expand,their current industry to include and ... by implementing a business,strategy. The Company,s strategy is ... its customer base., Solos Endoscopy expects continuous ...
Other Biology Technology:Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 2Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 3Micromet Announces Definitive Agreement for $40 Million Private Equity Placement 4MEDICA 2008 Returns in November 2Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market 2
...
... autofluorescent pigment lipofuscin accumulates in the ... neurons. The presence of lipofuscin granules ... microscopy in the central nervous system ... emission spectra, which overlaps with those ...
Purified anti-LAT...
Polyclonal Antibody to AHI1 / Jouberin...
Biology Products: